GSK926 (compound 3) is a selective histone lysine methyltransferase EZH2 inhibitor ( IC 50 =0.02 μM; K i =7.9 nM), with SAM-competitive and cell-active properties. GSK926 can be used in cancer research.
Products | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Histone Methyltransferase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.